Compare VIR & ABR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VIR | ABR |
|---|---|---|
| Founded | 2016 | 2003 |
| Country | United States | United States |
| Employees | N/A | 653 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2019 | N/A |
| Metric | VIR | ABR |
|---|---|---|
| Price | $8.82 | $5.35 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 5 |
| Target Price | ★ $19.43 | $9.90 |
| AVG Volume (30 Days) | 1.6M | ★ 3.8M |
| Earning Date | 05-06-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 15.42% |
| EPS Growth | ★ 17.49 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $68,556,000.00 | N/A |
| Revenue This Year | $270.22 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $9.29 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.16 | $4.73 |
| 52 Week High | $11.66 | $12.58 |
| Indicator | VIR | ABR |
|---|---|---|
| Relative Strength Index (RSI) | 42.38 | 49.72 |
| Support Level | $8.43 | $4.99 |
| Resistance Level | $10.33 | $5.43 |
| Average True Range (ATR) | 0.45 | 0.18 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 20.78 | 74.77 |
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.
Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily, SFR, and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment.